Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03201874 · ClinicalTrials.gov registry record · NA
iCanCope With Sickle Cell Pain
A NA study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT03201874 is a NA study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 137 participants.
The verdict
NCT03201874, a NA study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
The project will test a tailored web and smartphone-based application (iCanCope with SCD) to improve pain self-management and functioning in youth (aged 12-18) with sickle cell disease. The program will include goal setting, peer-based social support, and pain self-management training. The investigators will determine initial program effectiveness through a pilot three-site randomized controlled trial in 160 youth randomized to treatment compared to attention control.
Interventions
- BEHAVIORAL Education
- BEHAVIORAL Pain self-management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03201874
The ClinicalTrials.gov registry entry for NCT03201874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Education is the first listed.
NCT03201874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03201874 about?
NCT03201874 is a clinical study titled "iCanCope With Sickle Cell Pain". The project will test a tailored web and smartphone-based application (iCanCope with SCD) to improve pain self-management and functioning in youth (aged 12-18) with sickle cell disease. The program will include goal setting, peer-based social support, and pain self-management training. The investiga...
What is the current status of trial NCT03201874?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2018-01-01. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT03201874?
The interventions under investigation include: Education (BEHAVIORAL), Pain self-management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03201874?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.